MedPage Today on MSN
GLP-1 Microdosing and Longevity; Near 30% Weight Loss in Trial; 2025's Top Research
Meanwhile, people with overweight or obesity lost up to 11.3% more weight than placebo by week 36 with a novel GLP-1 agonist ...
MedPage Today on MSN
Virtual Weight-Loss Program Shows Potential for Vets With Serious Mental Illness
A 6-month fully remote weight-loss program tailored to veterans with serious mental illness yielded numerically greater ...
The ASA said it found this ad “encouraged new mothers to prioritise losing weight by using weight-loss medication, exploited ...
The Advertising Standards Authority also banned social media ads for SkinnyJab. It says the firms broke the law, and that ...
Excess body weight places extreme stress on the knees, accelerating cartilage damage and arthritis. A knee surgeon explains ...
Alongside the DASH diet, the Mediterranean diet is known to protect your ticker. One large analysis of more than 10,000 ...
A long-awaited decision published on Friday lays the groundwork for weight-loss drugs to be subsidised for more patients with ...
If you want to maintain healthy cholesterol levels, the first step is knowing your numbers and what they actually mean—but at ...
The ban comes after ads promoting the medicines 'targeted new mums' and 'exploited insecurities about body image' ...
The advertising watchdog has banned several adverts for prescription-only weight loss medications, citing concerns they ...
Everyday Health on MSN
New Obesity Drug Helped People Lose Nearly One-Third Their Body Weight
The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much weight loss comes with risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results